Dr. Natasha B. Hunter, MD
- Medicare services, 2024
- 253
- Medicare patients, 2024
- 115
- Part D claims, 2024
- 182
- Clinical trials
- 1
- MIPS score, 2024
- 94
- Practice address
- 825 Eastlake Avenue East, Seattle, WA 98109
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Hunter's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Natasha B. Hunter is a medical oncologist in Seattle, Washington
Dr. Hunter practices at Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center.
Dr. Hunter's NPI, 1669733572, was assigned on June 6, 2012. Dr. Hunter holds Washington license MD60861206.
- NPI
- 1669733572NPI Registry (opens in a new tab)
- Medicare PAC ID
- 1052622511
- NPI enumeration date
- June 6, 2012
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 40
- Medical school graduation
- 2012
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Natasha B. Hunter practices at Fred Hutchinson Cancer Center in Seattle, Washington
Dr. Hunter's primary practice is Fred Hutchinson Cancer Center, at 825 Eastlake Avenue East, Seattle, WA 98109.
- Fred Hutchinson Cancer Center825 Eastlake Avenue East, Seattle, WA 98109
Source: Dmand AI Affiliation Data
Dr. Natasha B. Hunter is affiliated with 2 sites of care and 1 medical group
Dr. Hunter's primary practice is Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center. Dr. Hunter is also affiliated with UW Medical Center - Montlake. The medical group on file is UW Physicians.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Natasha B. Hunter's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hunter practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Fred Hutchinson Cancer Center | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Fred Hutchinson Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Natasha B. Hunter is one of 145 medical oncologists in Washington
Medical oncology is Dr. Hunter's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Hunter is licensed in Washington.
Specialties and state licenses
- Medical oncology, WashingtonPrimary
Medical oncologists near Dr. Hunter
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Natasha B. Hunter billed Medicare for 253 services in 2024
CMS data shows 253 Medicare services from Dr. Hunter across 4 procedure codes in 2024, for 115 Medicare patients. Medicare paid $22,119 for them. Every service was in an office.
Dr. Hunter's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 2422024: 19320%
- Other services
- 2023: 02024: 60
Dr. Hunter compared with the Washington median for medical oncologists, 2024
- Dr. Hunter
- Washington median
- Medicare services
- 253vs 36230% below
- Medicare patients
- 115vs 13917% below
- Part D claims
- 63vs 18065% below
Medians across 131 medical oncologists in Washington with Dmand AI profiles that report each measure.
Dr. Hunter's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Hunter?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Hunter and other medical oncologists in Washington.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Natasha B. Hunter treated 115 Medicare patients in 2024, average age 73
CMS counts 115 Medicare patients who saw Dr. Hunter in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have cancer, and 67% have high cholesterol. Their average risk score is 1.34, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Hunter's median patient age at 61, with 96% women.
Dr. Hunter's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Chronic conditions among Dr. Hunter's Medicare patients, 2024
- Cancer75%
- High cholesterol67%
- High blood pressure53%
- Arthritis45%
- Anxiety29%
- Osteoporosis25%
- Mood disorders24%
- Depression23%
Share of Medicare patients with each condition. A patient can have several.
Dr. Hunter's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 61
Patient panel by sex, all payers
- Women96%
- Men3%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Natasha B. Hunter wrote 182 Medicare Part D claims in 2024
In 2024, Dr. Hunter wrote 182 Medicare Part D claims for 56 patients. 90% of them were for generic drugs. CMS names the drug for 63 of them, across 2 drugs with 11 or more claims each, at $1,539 in total drug cost. In 2023, CMS named 71 claims across 2 drugs.
Dr. Hunter's Part D claims by kind of drug, 2024
- Generic164 claims90%
- Brand-name18 claims10%
Dr. Hunter's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Hunter's Part D claims, 2024
- Opioids7%12 of 182 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 712024: 6311%
Drugs named by CMS: 2 in 2024, 2 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Natasha B. Hunter scored 94 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Hunter for performance year 2024, reported through an alternative payment model (APM). Dr. Hunter accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hunter as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Hunter's MIPS scores, performance year 2024
- 94of 100Final score
- 74.6of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Natasha B. Hunter has worked on 1 clinical trial
Dmand AI links Dr. Hunter to 1 clinical trial. Conditions studied include Breast Neoplasms and Breast Diseases. Open Payments lists research payments to Dr. Hunter that name 1 trial.
Conditions in Dr. Hunter's trials
- Breast Neoplasms
- Breast Diseases
Investigators on the most trials with Dr. Hunter
- Nihal Essa Abdulla, MD1 shared trial
- Maysa M. Abu-Khalaf, MD1 shared trial
- Aisha Ahmed, MD1 shared trial
Recent clinical trials with Dr. Hunter
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
Dr. Natasha B. Hunter received $2,945 in industry payments from 2019 to 2025
CMS Open Payments shows 13 general payments to Dr. Hunter from 7 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 72% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,115. It also lists 1 research payment totaling $10,130 in 2022, naming 1 clinical trial.
General payments to Dr. Hunter by program year, 2019 to 2025
General payments to Dr. Hunter by kind, 2019 to 2025
- Consulting fees$2,11572%
- Food and beverage$81828%
- Education$120%
Companies that paid Dr. Hunter the most, 2019 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Natasha B. Hunter's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Natasha B. Hunter
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Natasha B. Hunter's NPI number?
Dr. Natasha B. Hunter's NPI number is 1669733572. It was assigned on June 6, 2012, and it is active in the NPI Registry.
What kind of doctor is Dr. Natasha B. Hunter?
Dr. Natasha B. Hunter is a medical oncologist in Seattle, Washington. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Natasha B. Hunter practice?
Dr. Hunter practices at 825 Eastlake Avenue East, Seattle, WA 98109. Dr. Hunter's primary practice is Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center.
What is Dr. Natasha B. Hunter's medical license number?
Dr. Hunter holds Washington license MD60861206.
Which hospitals is Dr. Natasha B. Hunter affiliated with?
Dr. Hunter practices at Fred Hutchinson Cancer Center in Seattle, Washington. Dr. Hunter is also affiliated with UW Medical Center - Montlake.
What medical group is Dr. Natasha B. Hunter part of?
Dr. Hunter is linked to UW Physicians.
Does Dr. Natasha B. Hunter accept Medicare?
Yes. CMS data shows Dr. Hunter billed Medicare for 253 services in 2024, and Dr. Hunter accepts Medicare assignment.
Does Dr. Natasha B. Hunter offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Hunter as offering telehealth services.
What is Dr. Natasha B. Hunter's MIPS score?
Dr. Hunter's MIPS final score for performance year 2024 is 94 out of 100, reported through an alternative payment model (APM).
How many Medicare patients does Dr. Natasha B. Hunter see?
CMS counts 115 Medicare patients who saw Dr. Hunter in 2024, with an average age of 73.
Show 5 more questionsShow fewer questions
What services does Dr. Natasha B. Hunter bill to Medicare?
In 2024, Dr. Hunter's most billed Medicare services were office visit, established patient (99215), medicare service (G2211) and office visit, established patient (99214).
What drugs does Dr. Natasha B. Hunter prescribe most?
In 2024 Medicare Part D data, Dr. Hunter's most prescribed drugs by claims were Letrozole and Anastrozole.
Has Dr. Natasha B. Hunter received payments from drug or device companies?
CMS Open Payments shows $2,945 in general payments to Dr. Hunter from 7 companies from 2019 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.
How long has Dr. Natasha B. Hunter been practicing?
Dr. Hunter graduated from medical school in 2012, 14 years ago.
Does Dr. Natasha B. Hunter do research?
Dr. Hunter has worked on 1 clinical trial.
Selling to medical oncology practices?
See medical oncologists in Washington by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card